Incidence of Thyroid Dysfunction During Interferon Alfa-2b and Ribavirin Therapy in Men With Chronic Hepatitis C

Archives of Internal Medicine
doi 10.1001/archinte.164.21.2371
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Medical Association (AMA)

Related search

Pegylated Interferon and Ribavirin Combination Therapy for Chronic Hepatitis C Associated With Thyroid Dysfunction

Acta Hepatologica Japonica
Hepatology
2013English

Peginterferon Alfa-2b and Ribavirin Therapy in Kuwaiti Patients With Chronic Hepatitis C Virus Infection

Eastern Mediterranean Health Journal
Medicine
2011English

Oxidative Stress and Antioxidant Defense in Patients With Chronic Hepatitis C Patients Before and After Pegylated Interferon Alfa-2b Plus Ribavirin Therapy

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2006English

Incidence of and Risk Factors for Thyroid Dysfunction During Peginterferon Α and Ribavirin Treatment in Patients With Chronic Hepatitis C

Korean Journal of Internal Medicine
Internal Medicine
2015English

Treatment of Chronic Hepatitis C With Recombinant Interferon Alfa-2b for Nine Months.

Gut
Gastroenterology
1993English

Renal Dysfunction With Telaprevir in Combination With Peginterferon Alfa-2b and Ribavirin Therapy

Acta Hepatologica Japonica
Hepatology
2012English

Depressive Episode Incidence in Patients With Chronic Hepatitis C Treated With Pegylated Interferon and Ribavirin

Arquivos de Gastroenterologia
Gastroenterology
2016English

Interferon Alpha-2b Therapy in Chronic Hepatitis Delta

Hepatitis Monthly
HepatologyInfectious Diseases
2014English

Hepatitis C Virus Markers in Patients With Acute Post-Transfusion Hepatitis Treated With Interferon Alfa-2b.

Gut
Gastroenterology
1993English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy